Ann Gils

220 papers receiving 8.6k citations

Ann Gils's Hit Papers

Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease 2015 · 650 citations
6500+3+7Years since publication200400600

Peers

Ann Gils
Comparison fields: 5 of 130
  • Genetics 3.8k
  • Hematology 1.4k
  • Immunology 1.8k
  • Cancer Research 1.2k
  • Epidemiology 1.6k
Replace Hideaki Nakajima with:
Hideaki Nakajima Japan
Richard Görlick United States
Edward N. Harris United States
Lennart Truedsson Sweden
H. Miles Prince Australia
Juri Kopolovic Israel
Pauli Puolakkainen Finland
Michael A. Nalesnik United States
Masja de Haas Netherlands
Stefan Niewiarowski United States
Ann Gils relative to Hideaki Nakajima Japan Hideaki Nakajima's profile →
Citations per field
00.5×3.6×
Hideaki Nakajima · 1×
Citations per year

Countries citing papers authored by Ann Gils

Since Specialization
Citations

This map shows the geographic impact of Ann Gils's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Gils with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Gils more than expected).

Fields of papers citing papers by Ann Gils

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Gils. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Gils. The network helps show where Ann Gils may publish in the future.

Co-authors

The 25 scholars most cited alongside Ann Gils, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ann Gils Line = papers co-authored together Ann Gils links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 224 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
Hit paper breakdown →
2015650
2 2013287
3 2002252
4 2014226
5 2014193
6 2018184
7 2012183
8 2012171
9 2014151
10 2004143
11 2013136
12 2015130
13 2015125
14 2018124
15 2017123
16 2012110
17 2015105
18 2018103
19 2014103
20 2014102

About Ann Gils

Ann Gils is a scholar working on Genetics, Hematology, Immunology, Cancer Research and Molecular Biology, having authored 224 papers that have together received 8.7k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (75 papers), Blood Coagulation and Thrombosis Mechanisms (53 papers), Protease and Inhibitor Mechanisms (43 papers), Biosimilars and Bioanalytical Methods (29 papers), Monoclonal and Polyclonal Antibodies Research (20 papers), Immunodeficiency and Autoimmune Disorders (18 papers), Microscopic Colitis (17 papers) and Signaling Pathways in Disease (13 papers). The work is most often cited by research in Genetics (3.8k citations), Hematology (1.4k citations), Immunology (1.8k citations), Cancer Research (1.2k citations) and Epidemiology (1.6k citations). Ann Gils has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Paul Declerck, Séverine Vermeire, Niels Vande Casteele, Marc Ferrante, Gert Van Assche, Paul Rutgeerts, Griet Compernolle, Thomas Van Stappen, Erwin Dreesen and Vera Ballet. Their work appears in journals such as Journal of Thrombosis and Haemostasis, Journal of Crohn s and Colitis, Thrombosis and Haemostasis, Inflammatory Bowel Diseases and Therapeutic Drug Monitoring.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact